Quantexa Named a Luminary in Everest Group’s Innovation Watch Report
Notified -
Globe Newswire2-07-2025, 15:00
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51
